Question 1

What are the key details for the project “Therapeutic Targeting Of The Human Islet Environment (UC4)”?

Accepted Answer

The project “Therapeutic Targeting Of The Human Islet Environment (UC4)” is an infrastructure initiative in the Government sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Therapeutic Targeting Of The Human Islet Environment (UC4)”?

Accepted Answer

The status recorded for “Therapeutic Targeting Of The Human Islet Environment (UC4)” is archived.

Question 3

Who are the main government, EPC, and private stakeholders for “Therapeutic Targeting Of The Human Islet Environment (UC4)”?

Accepted Answer

Taiyo maps the stakeholders of “Therapeutic Targeting Of The Human Islet Environment (UC4)”: government bodies (National Institutes of Health (NIH), US Department of Health and Human Services (HHS), US Government).

Question 4

What is the budget and commercial profile for the project “Therapeutic Targeting Of The Human Islet Environment (UC4)”?

Accepted Answer

Taiyo normalizes the budget of “Therapeutic Targeting Of The Human Islet Environment (UC4)” to USD 12000000.

Question 5

Where can I verify the source and access all details for “Therapeutic Targeting Of The Human Islet Environment (UC4)”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=290656). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	archived
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	This Funding Opportunity Announcement (FOA) solicits applications for projects to develop strategies to target the human pancreatic environment in-vivo to deliver cell-based therapeutics, regulatory molecules or gene constructs that can protect or replenish the functional beta cell mass, or to develop synthetic sentinel biomarkers to safely monitor beta cell stress or disease initiation prior to the appearance of autoantibodies in individuals at risk of developing Type 1 Diabetes (T1D). Successful applicants will join the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase functional human beta cell mass in vivo through the controlled manipulation of beta cell replication, islet cell plasticity, or the reprogramming of pancreatic non-beta cells into beta-like cells. CTAR is part of the Human Islet Research Network (HIRN).
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Therapeutic Targeting Of The Human Islet Environment (UC4)

Project Information FAQ

Project Information